J. Miser

2.9k total citations
37 papers, 2.3k citations indexed

About

J. Miser is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Surgery. According to data from OpenAlex, J. Miser has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 12 papers in Neurology and 7 papers in Surgery. Recurrent topics in J. Miser's work include Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (12 papers) and Lymphoma Diagnosis and Treatment (5 papers). J. Miser is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Neuroblastoma Research and Treatments (12 papers) and Lymphoma Diagnosis and Treatment (5 papers). J. Miser collaborates with scholars based in United States, France and Spain. J. Miser's co-authors include Timothy J. Triche, Timothy J. Kinsella, Andrea Cavazzana, J. Ashley Jefferson, Maria Tsokos, Robert Wesley, Ian Magrath, Jacqueline Whang‐Peng, Tor Knutsen and Mark A. Israel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

J. Miser

37 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Miser United States 22 1.4k 637 584 505 474 37 2.3k
Erlinda Etcubanas United States 25 1.0k 0.7× 580 0.9× 319 0.5× 260 0.5× 481 1.0× 38 1.9k
Jörn Treuner Germany 23 2.0k 1.4× 831 1.3× 458 0.8× 649 1.3× 555 1.2× 44 2.7k
N Jaffe United States 25 1.2k 0.8× 635 1.0× 167 0.3× 429 0.8× 308 0.6× 73 2.1k
Inga‐Marie Schaefer United States 26 1.2k 0.9× 536 0.8× 515 0.9× 508 1.0× 525 1.1× 80 2.5k
D Hammond United States 23 861 0.6× 634 1.0× 383 0.7× 281 0.6× 472 1.0× 48 2.3k
J M Zucker France 18 637 0.4× 404 0.6× 608 1.0× 155 0.3× 505 1.1× 29 1.7k
Brenda Caparros United States 15 1.8k 1.3× 673 1.1× 177 0.3× 830 1.6× 209 0.4× 18 2.3k
Angela Cioffi France 22 1.5k 1.1× 958 1.5× 343 0.6× 387 0.8× 162 0.3× 55 2.2k
Michela Versari Italy 25 1.9k 1.3× 655 1.0× 154 0.3× 989 2.0× 484 1.0× 34 2.5k
Philippe Terrier France 31 2.2k 1.5× 963 1.5× 647 1.1× 1.2k 2.4× 519 1.1× 60 3.3k

Countries citing papers authored by J. Miser

Since Specialization
Citations

This map shows the geographic impact of J. Miser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Miser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Miser more than expected).

Fields of papers citing papers by J. Miser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Miser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Miser. The network helps show where J. Miser may publish in the future.

Co-authorship network of co-authors of J. Miser

This figure shows the co-authorship network connecting the top 25 collaborators of J. Miser. A scholar is included among the top collaborators of J. Miser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Miser. J. Miser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenthal, Joseph, Ellen Bolotin, Anna Pawłowska, et al.. (2008). High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors. Bone Marrow Transplantation. 42(5). 311–318. 21 indexed citations
2.
3.
Arndt, Carola A.S., Antonio G. Nascimento, G. Schroeder, et al.. (1998). Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. European Journal of Cancer. 34(8). 1224–1229. 39 indexed citations
4.
Provisor, Arthur J., Lawrence J. Ettinger, James B. Nachman, et al.. (1997). Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.. Journal of Clinical Oncology. 15(1). 76–84. 363 indexed citations
5.
Weinberger, Edward, et al.. (1995). MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor.. American Journal of Roentgenology. 165(4). 915–920. 44 indexed citations
6.
Henry‐Amar, M., Timothy J. Triche, Marc E. Horowitz, et al.. (1995). Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis?. European Journal of Cancer. 31(3). 307–314. 56 indexed citations
7.
Smith‐Sørensen, Birgitte, Stephen Friend, Yu-Xin Yan, et al.. (1994). Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.. Journal of Clinical Oncology. 12(5). 925–930. 145 indexed citations
8.
Perlman, Elizabeth J., Paul S. Dickman, Frederic B. Askin, et al.. (1994). Ewing's sarcoma—Routine diagnostic utilization of MIC2 analysis: A pediatric oncology group/children's cancer group intergroup study. Human Pathology. 25(3). 304–307. 110 indexed citations
9.
Adamson, Peter C., Frank M. Balis, J. Miser, et al.. (1992). Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.. PubMed. 52(3). 521–4. 27 indexed citations
10.
Miser, J., et al.. (1992). Case report 760. Skeletal Radiology. 21(8). 543–5. 23 indexed citations
11.
Hutchinson, Raymond J., James C. Sisson, Brahm Shapiro, et al.. (1992). 131-I-Metaiodobenzylguanidine Treatment in Patients with Refractory Advanced Neuroblastoma. American Journal of Clinical Oncology. 15(3). 226–232. 37 indexed citations
12.
Hartman, Kip R., Timothy J. Triche, Timothy J. Kinsella, & J. Miser. (1991). Prognostic value of histopathology in ewing's sarcoma. Long-term follow-up of distal extremity primary tumors. Cancer. 67(1). 163–171. 45 indexed citations
13.
Miser, J., Timothy J. Kinsella, Timothy J. Triche, et al.. (1988). Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance.. Journal of Clinical Oncology. 6(3). 484–490. 67 indexed citations
14.
Miser, J., et al.. (1988). Ewing's sarcoma is an undifferentiated neuroectodermal tumor.. Progress in clinical and biological research. 271. 487–98. 14 indexed citations
15.
16.
Miser, J., Timothy J. Kinsella, Timothy J. Triche, et al.. (1987). Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.. Journal of Clinical Oncology. 5(8). 1191–1198. 253 indexed citations
17.
Miser, J., Timothy J. Kinsella, Timothy J. Triche, et al.. (1987). Treatment of peripheral neuroepithelioma in children and young adults.. Journal of Clinical Oncology. 5(11). 1752–1758. 100 indexed citations
18.
Miser, J., et al.. (1986). Treatment of pelvic sarcomas with intensive combined modality therapy. International Journal of Radiation Oncology*Biology*Physics. 12. 134–134. 1 indexed citations
19.
Whang‐Peng, Jacqueline, et al.. (1986). Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genetics and Cytogenetics. 21(3). 185–208. 261 indexed citations
20.
Miser, J., et al.. (1982). Pharmacokinetic study of indicine N-oxide in pediatric cancer patients. Cancer Chemotherapy and Pharmacology. 10(1). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erlinda Etcubanas Breakdown of academic impact, for papers by Jörn Treuner Breakdown of academic impact, for papers by N Jaffe Breakdown of academic impact, for papers by Inga‐Marie Schaefer Breakdown of academic impact, for papers by D Hammond Breakdown of academic impact, for papers by J M Zucker Breakdown of academic impact, for papers by Brenda Caparros Breakdown of academic impact, for papers by Angela Cioffi Breakdown of academic impact, for papers by Michela Versari Breakdown of academic impact, for papers by Philippe Terrier
Rankless by CCL
2026